Platelet production promoting agent
The invention relates to a polypeptide wherein at least one of the amino, carboxyl, mercapto or guanidino group in a polypeptide molecule having human granulocyte colony stimulating factor activity is chemically modified by a chemical modifying agent, and a platelet production promoter comprising said polypeptide, a method for treating a patient with decreased platelet counts comprising administering an effective amount of said polypeptide to the patient, the use of said polypeptide for the production of pharmaceutical compositions which are useful for the treatment of the patient with decreased platelet counts, and the compositions for treating the patient with decreased platelet counts, which comprises an effective dose of said polypeptide in a pharmaceutically acceptable dosage form with a pharmaceutical acceptable carrier.
1. A method for increasing the platelet counts of a patient with decreased platelet counts comprising administering an effective amount of a modified polypeptide having an amino acid sequence wherein the first amino acid, threonine is replaced by alanine, the third amino acid, leucine is replaced by threonine, the fourth amino acid, glycine is replaced by tyrosine, the fifth amino acid, proline is replaced by arginine and the seventeenth amino acid, cysteine is replaced by serine, respectively in SEQ ID NO: 1, wherein at least one group of the amino, carboxyl, mercapto or guanidino group in the molecule of a polypeptide is chemically modified with a polyalkylene glycol derivative or a stylene-maleic acid copolymer.
2. The method according to claim 1 , wherein a polyalkylene glycol derivative is selected from the group consisting of a polyethylene glycol derivative, a polypropylene glycol derivative, and a derivative of polyethylene glycol-polypropylene glycol copolymer.
3. The method according to claim 1 , wherein the amino group is modified with
(a) a polyalkylene glycol derivative having the formula (I):
R 1 -(M) n —X—R 2 (I)
wherein R 1 represents alkyl or alkanoyl group; M represents the formula:
—OCH 2 CH 2 —, —OCH 2 CH 2 CH 2 —
or
—(OCH 2 CH 2 ) r —(OCH 2 CH 2 CH 2 ) s —
wherein r and s have any variable positive integral values, which are the same or different; n has any variable positive integral values; X represents a single bond, O, NH, or S; and R 2 represents the formula:
wherein R 3 represents OH, halogen, or the formula:
X a -(M a ) na -R 1a
wherein X a , M a , R 1a and na are identical to said X, M, R 1 and n, respectively, and Y represents halogen or the formula:
-Z-(CH 2 ) p —(O) m —W
wherein Z represents O, S, or NH; W represents a carboxyl group, an active derivative thereof, or the formula:
wherein R 4 represents an alkyl group; and Hal represents halogen, and p has an integral value of 1 to 6; and m has a value of 0 or 1,
—(CO) ma —(CH 2 ) t —W a
wherein W a and ma are identical to said W and m, respectively; and t has an integral value of from 0 to 6, or
wherein Hal a , pa and R 4a are identical to said Hal, p and R 4 , respectively, or
(b) a styrene-maleic acid copolymer having the formula (II):
wherein u and v have any variable positive integral values, which are the same or different; and R 5 represents a hydrogen atom, or an alkyl group.
4. The method according to claim 1 , wherein the carboxyl group is modified with a polyalkylene glycol derivative having the formula (III):
R 1b -(M b ) nb -NH 2 (III)
wherein M b , R 1b and nb are identical to said M, R 1 and n, respectively.
5. The method according to claim 1 , wherein the mercapto group is modified with
(a) a polyalkylene glycol derivative having the formula (IV):
wherein M c , R 1c , and nc are identical to said M, R 1 , and n, respectively, or
(b) a styrene-maleic acid copolymers having the formula (V):
wherein R 5a , ua, and va are identical to said R 5 , U and V, respectively, and one of Q and R represents a carboxyl group, and the other represents the formula:
herein pb is identical to said p.
6. The method according to claim 1 , wherein the guanidino group is modified with a polyalkylene glycol derivatives having the formula (VI):
wherein q has a value of 1 or 2, and M d , R 1d , and nd are identical to said M, R1, and n, respectively.
7. The method according to claim 1 , wherein the amino group is modified by binding to a group represented by the following formula (Ia):
R 1 -(M) n -X—R 2a — (Ia)
wherein R 1 represents an alkyl or alkanoyl group; M represents the formula:
—OCH 2 CH 2 —, —OCH 2 CH 2 CH 2 —
or
—(OCH 2 CH 2 ) r —(OCH 2 CH 2 CH 2 ) s —
wherein r and s have any variable positive integral values, which are the same or different; n has any variable positive integral value; X represents a single bond, O, NH, or S; and R 2a represents the formula:
wherein R 3a represents OH, halogen, or the formula:
—X a -(M a ) na -R 1a
wherein X a , M a , R 1a and na are identical to said X, M, R 1 and n, respectively,
and Y a represents a single bond, the formula:
-Z-(CH 2 ) p —(O) m —CO—
wherein Z represents O, S, or NH; p has an integral value of from 1 to 6; and m has a value of 0 or 1, or the formula:
—(CO) ma —(CH 2 ) t —CO—
wherein ma is identical to said m; and t has an integral value of from 0 to 6.
8. The method according to claim 7 , wherein Y a represents the formula:
-Z-(CH 2 ) p —O—CO—
wherein Z represents O, S, or NH; and p has an integral value of from 1 to 6.